Teladoc Health
TDOC
5.56
-0.21
-3.64%
Teladoc Health
US · TDOC
#3241 by market cap
Listed 2015
5.56
-0.21
-3.64%
Live - 5344 symbols - heartbeat 298s ago
· 2026-10-08 09:19
Pre-market
5.55
-0.18%
After-hours
5.56
0.00%
- Market cap
- 1.01B
- P/E (TTM)i
- -5.62
- P/Bi
- 0.77
- EPSi
- -1.14
- Div yieldi
- 0.00%
- 52W posi
- 21%
Reader sentiment
Are you bullish or bearish on TDOC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 84.67% +0.05pp
- Institutions
- 413
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund59.59%
Hedge Fund17.95%
Public Company3.12%
Private Company2.10%
VC/PE Fund1.10%
Individual/Insider0.69%
Government Pension Fund0.40%
Insurance Company0.26%
Family Office/Trust0.10%
Other14.68%
Top holders as of 2026-06-30
BlackRock
8.93% · 16.22M sh
Vanguard Portfolio Management, LLC
6.98% · 12.69M sh
Vanguard Capital Management, LLC
5.04% · 9.15M sh
Point72 Asset Management, L.P.
4.54% · 8.24M sh
Renaissance Technologies Corp.
4.44% · 8.07M sh
Voss Capital, LP
4.43% · 8.05M sh
Dimensional Fund Advisors
4.06% · 7.37M sh
State Street Global Advisors
2.73% · 4.96M sh
American Century Investment Management
2.69% · 4.89M sh
Pacific Investment Management Company LLC
2.57% · 4.67M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 33 sells
| Name | Role | Stake |
|---|---|---|
| Charles Divita | Chief Executive Officer | 0.26% |
| David Snow | Independent Non-Executive Chairperson | 0.09% |
| Mala Murthy | Chief Financial Officer | 0.08% |
| Adam Vandervoort | Chief Legal Officer | 0.06% |
| Kelly Bliss | President of U.S. Group Health | 0.05% |
| Catherine Jacobson | Independent Director | 0.04% |
| Carlos Nueno | President of International | 0.04% |
| David Shedlarz | Independent Director | 0.03% |
| Sandra Fenwick | Independent Director | 0.02% |
| Joseph Catapano | Chief Accounting Officer | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Sale | -655 | $5.65 |
| 2026-09-30 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Retained | +1,428 | -- |
| 2026-09-10 | Charles Divita | Chief Executive Officer | Derivative Exercise and Sale | -17,805 | $6.10 |
| 2026-09-10 | Charles Divita | Chief Executive Officer | Intent to Sell (Form 144) | -17,805 | $6.10 |
| 2026-09-09 | Charles Divita | Chief Executive Officer | Derivative Exercise and Retained | +24,997 | -- |
| 2026-09-02 | Fernando Madeira | President of BetterHelp | Derivative Exercise and Sale | -15,251 | $6.30–6.51 |
| 2026-09-02 | Fernando Madeira | President of BetterHelp | Intent to Sell (Form 144) | -9,812 | $6.51 |
| 2026-09-01 | Charles Divita | Chief Executive Officer | Derivative Exercise and Sale | -18,327 | $6.30 |
| 2026-09-01 | Charles Divita | Chief Executive Officer | Intent to Sell (Form 144) | -18,327 | $6.30 |
| 2026-09-01 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Sale | -274 | $6.30 |
| 2026-09-01 | Adam Vandervoort | Chief Legal Officer | Derivative Exercise and Sale | -7,573 | $6.30 |
| 2026-09-01 | Adam Vandervoort | Chief Legal Officer | Intent to Sell (Form 144) | -7,573 | $6.30 |
| 2026-09-01 | Fernando Madeira | President of BetterHelp | Intent to Sell (Form 144) | -5,439 | $6.30 |
| 2026-09-01 | Kelly Bliss | President of U.S. Group Health | Derivative Exercise and Sale | -7,357 | $6.30 |
| 2026-09-01 | Kelly Bliss | President of U.S. Group Health | Intent to Sell (Form 144) | -7,357 | $6.30 |
| 2026-09-01 | Carlos Nueno | President of International | Derivative Exercise and Sale | -6,200 | $6.30 |
| 2026-09-01 | Carlos Nueno | President of International | Intent to Sell (Form 144) | -6,200 | $6.30 |
| 2026-08-31 | Charles Divita | Chief Executive Officer | Derivative Exercise and Retained | +25,916 | -- |
| 2026-08-31 | Joseph Catapano | Chief Accounting Officer | Derivative Exercise and Retained | +598 | -- |
| 2026-08-31 | Michael Grasher | Chief Financial Officer | Other Derivative Acquisition | +239,616 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:19:52 · For reference only, not investment advice and not tailored to your situation.